Literature DB >> 11604984

MSH2 and MLH1 immunodetection and the prognosis of colon cancer.

J Perrin1, J Gouvernet, D Parriaux, T Noguchi, M H Giovannini, M Giovannini, J R Delpero, D Birnbaum, G Monges.   

Abstract

MSH2 and MLH1 are proteins involved in DNA reparation. They are mutated in some forms of colon cancer, i.e. hereditary non-polyposis carcinomas and a subset of sporadic carcinomas. We have studied the expression of MSH2 and MLH1 in a retrospective series of 225 colorectal carcinomas by immunohistochemistry. The results were compared to molecular tests of microsatellite instability using amplification by PCR of BAT-25 and BAT-26 repeated sequences and to histoclinical data. Positivity of both proteins was never associated with MSI phenotype. MSH2 and/or MLH1 negative tumors were frequently tumors of the proximal colon; in this subpopulation or proximal tumors, MSH2 and/or MLH1 negativity was associated with a longer disease-free survival.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11604984     DOI: 10.3892/ijo.19.5.891

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  4 in total

1.  Loss of hMSH2 gene expression correlates with improved survival in patients with sporadic colorectal cancer.

Authors:  Ewa Langner; Karolina Przybylowska; Radzislaw Trzcinski; Michal Mik; Przemyslaw Galbfach; Beata Smolarz; Hanna Romanowicz-Makowska; Janusz Smigileski; Andrzej Kulig; Adam Dziki
Journal:  J Genet       Date:  2010-04       Impact factor: 1.166

Review 2.  [Clinical, pathological and molecular prognostic factors in colorectal carcinomas].

Authors:  S E Baldus
Journal:  Pathologe       Date:  2003-01-21       Impact factor: 1.011

3.  Survival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients.

Authors:  Vittoria Stigliano; Daniela Assisi; Maurizio Cosimelli; Raffaele Palmirotta; Diana Giannarelli; Marcella Mottolese; Lupe Sanchez Mete; Raffaello Mancini; Vincenzo Casale
Journal:  J Exp Clin Cancer Res       Date:  2008-09-19

4.  Integrated analysis highlights APC11 protein expression as a likely new independent predictive marker for colorectal cancer.

Authors:  Youenn Drouet; Isabelle Treilleux; Alain Viari; Sophie Léon; Mojgan Devouassoux-Shisheboran; Nicolas Voirin; Christelle de la Fouchardière; Brigitte Manship; Alain Puisieux; Christine Lasset; Caroline Moyret-Lalle
Journal:  Sci Rep       Date:  2018-05-09       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.